...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: if RVX gets bought out it wouldn't surprise me if DM....?

desides to go down a few more rabbit holes with PFE.Thus we may not see a deal for Zenith for min to max one to three more years IMO? Why would't he stay the course if RVX sells?

 

I imagine tho that many shareholders would really like an op to collect some cash anytime now? What would Hepa want/need to do? Would we have the votes if we get an offer?

 

glta

 

Share
New Message
Please login to post a reply